Bloomberg |
AstraZeneca Fails to Win FDA Backing for Diabetes Treatment
Bloomberg AstraZeneca Plc failed to win U.S. approval for a new diabetes treatment that combines two of its existing drugs after regulators asked for additional data that may require new clinical trials. The drugmaker will work closely with the Food and Drug … FDA asks for more clinical trials to AstraZeneca diabetes treatmentPulse Headlines FDA Holds Off Approval Of AstraZeneca Diabetes TreatmentLaw360 (subscription) FDA declines approval of AZN's diabetes treatmentSeeking Alpha StreetInsider.com all 98 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.